Associations between PIK3CA Mutations and Disease Free Survival in Patients with HR+, HER2− Tumors Treated with Adjuvant Hormonal Therapy: A Real-World Study in Croatia

• Κύριοι συγγραφείς: Dora Čerina Pavlinović (Συγγραφέας), Natalija Dedić Plavetić (Συγγραφέας), Ingrid Belac Lovasić (Συγγραφέας), Robert Šeparović (Συγγραφέας), Josipa Flam (Συγγραφέας), Marija Pancirov (Συγγραφέας), Žarko Bajić (Συγγραφέας), Snježana Tomić (Συγγραφέας), Eduard Vrdoljak (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Wiley, 2024-01-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Introduction. Disease recurrence in patients with the early hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) breast tumor subtype is particularly challenging to manage due to its complex and very heterogeneous biological nature. Namely, due to primary and se...